Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD): a Prospective Randomized Controlled Study

Launched by NINGBO NO. 1 HOSPITAL · Dec 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of tracheal intubation, which is a procedure used to help patients breathe during a specific type of surgery called endoscopic submucosal dissection (ESD). The trial will compare traditional tracheal intubation to a newer technique called endoscopy-assisted tracheal intubation, which uses advanced video technology to make the process easier and possibly safer. The researchers aim to enroll 148 patients aged between 18 and 75 who are scheduled for ESD at Ningbo University Affiliated First Hospital over the next two years.

To participate, patients need to agree to the study and sign a consent form. They will provide some basic health information and go through a preoperative preparation period. After the surgery, the researchers will evaluate any discomfort the patients may experience. However, not everyone can join the study; for instance, individuals under 18, those with serious heart or lung issues, or pregnant women are excluded for safety reasons. This trial is not yet recruiting participants, but it aims to gather important information that could improve how tracheal intubation is performed in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing endoscopic submucosal dissection (ESD) at Ningbo University Affiliated First Hospital from December 2024 to December 2026.
• • Aged between 18 and 75 years.
• • Patients who voluntarily agree to participate in the study and sign the informed consent form.
• Exclusion Criteria:
• • Individuals under 18 years of age.
• • Patinents unwilling or unable to provide informed consent.
• • Patients with severe chronic cardiac or pulmonary disease, or those who have required hospitalization for coronary or cerebrovascular events or radiotherapy within the past 3 months.
• • Patients with severe abdominal symptoms such as severe pain, bloating, or nausea.
• • Patients with inadequate preoperative preparation.
• • Individuals requiring lifelong anticoagulant therapy, those with severe bleeding disorders, or those who have recently taken anticoagulant or antiplatelet medications.
• • Pregnant or breastfeeding individuals.